Global API sourcing simplified
We connect API buyers and suppliers worldwide with speed, trust, and full transparency.

Filters

Filters
Filter
Custom request?
Type
Production region
Qualifications
Show more
Country of origin
Show more

Potassium hydrogen carbonate API Manufacturers & Suppliers

2 verified results
Take control of your API sourcing
Submit a Special Inquiry and have Pharmaoffer activate verified suppliers.

Commercial-scale Suppliers

Distributor
Produced in  Unknown
|

Employees: 275+

|
Audit Report: Currently Eurofins has no report for this supplier. Contact them to let them know you're interested!
Certifications: GMP
|
MSDS
|
BSE/TSE
|
ISO9001
|
CoA

All certificates

GMP
MSDS
BSE/TSE
ISO9001
CoA
Producer
Produced in  France
|
Audit Report: Click here for more information on Eurofins audit reports
Certifications: GMP
|
CoA

All certificates

GMP
CoA
Not active
Take control of your API sourcing
Submit a Special Inquiry and have Pharmaoffer activate verified suppliers.
Get full market intelligence report
Get full market intelligence report
€399,-
All Potassium hydrogen carbonate data. Full access. Full negotiation power
When insight is your advantage
Full data, full access, full negotiation power
Total market transparency Total market transparency
|
Supplier trade data access Supplier trade data access
|
Buyer / supplier flow comparison Buyer / supplier flow comparison
Trusted by 30,000+ registered pharma professionals:
Reach multinationals, SMEs, compounding pharmacies & more!
Procaps
Pfizer
Reckitt
Sanofi
Blau
Abbvie

Potassium bicarbonate | CAS No: 298-14-6 | GMP-certified suppliers

A medication that neutralizes gastric acid and replenishes potassium to support electrolyte balance and gastrointestinal comfort in patients requiring antacid and potassium supplementation.

Therapeutic categories

Agents causing hyperkalemiaAlimentary Tract and MetabolismAnionsCarbon Compounds, InorganicCarbonatesCarbonic Acid
Generic name
Potassium bicarbonate
Molecule type
small molecule
CAS number
298-14-6
DrugBank ID
DB11098
Approval status
Approved drug
ATC code
A12BA04

Primary indications

  • Potassium bicarbonate is used as an antacid, electrolyte replenisher and potassium supplement
  • It can also be used as an excipient in drug formulations
  • An antacid is a medication used to neutralize gastric acid in a short timeframe after ingestion and the effect is soon overcome by meal-stimulated acid secretion

Product Snapshot

  • Potassium bicarbonate is available as an oral small molecule in multiple formulations including tablets, capsules, suspensions, and powders
  • It is primarily utilized as an antacid, electrolyte replenisher, and potassium supplement, and also serves as an excipient in pharmaceutical formulations
  • The compound is approved for use in major regulatory markets including the US, Canada, and the EU

Clinical Overview

Potassium bicarbonate (CAS Number 298-14-6) is a white, crystalline compound characterized by a slightly alkaline and salty profile. It is synthesized through the reaction of carbon dioxide with an aqueous potassium carbonate solution. Medicinally, it is primarily employed as an antacid agent, electrolyte replenisher, and potassium supplement. It is recognized by the U.S. Food and Drug Administration (FDA) as a Generally Recognized As Safe (GRAS) ingredient for over-the-counter antacid formulations.

Pharmacologically, potassium bicarbonate belongs to the class of organic carbonic acids. Its antacid effect is achieved by neutralizing gastric hydrochloric acid, thereby increasing the pH of the gastrointestinal environment. This elevation in pH results in decreased activity of pepsin, a proteolytic enzyme that contributes to mucosal ulceration in the presence of acid. Potassium, the principal intracellular cation, plays a crucial role in maintaining nerve impulse conduction, renal function, acid-base balance, and cellular metabolism. The bicarbonate component contributes to the generation of carbon dioxide, which may cause eructation, a known side effect in some patients.

Absorption and elimination characteristics are consistent with its ionic nature. Potassium bicarbonate is mainly renally excreted, and its systemic potassium levels must be monitored to avoid hyperkalemia, particularly in patients with impaired renal function or those receiving concomitant medications that alter potassium balance.

Potassium bicarbonate is incorporated not only as an active pharmaceutical ingredient but also as an excipient in various drug formulations. Its clinical use is aligned with conditions requiring rapid neutralization of gastric acidity and potassium supplementation.

From a sourcing perspective, high purity and compliance with pharmacopeial standards are essential. The API should be procured from suppliers with validated manufacturing processes ensuring consistent crystalline form and minimal impurities. Attention to stability, especially moisture control, is critical to maintain product quality during storage and formulation.

Identification & chemistry

Generic name Potassium bicarbonate
Molecule type Small molecule
CAS 298-14-6
UNII HM5Z15LEBN
DrugBank ID DB11098

Pharmacology

SummaryPotassium bicarbonate acts primarily as an antacid by neutralizing gastric hydrochloric acid, thereby increasing gastrointestinal pH and inhibiting pepsin activity. It serves as a source of potassium ions, essential for maintaining nerve impulse conduction, acid-base balance, and cellular function across multiple tissues. The compound also releases CO2 during its neutralization process, which can lead to gastrointestinal gas formation.
Mechanism of actionThe antacid potential of potassium bicarbonate is attained by increasing the gastrointestinal pH by neutralizing hydrochloric acid. The increase in pH results in suppression of the action of pepsin which is the enzyme that exacerbates ulceration due to the presence of acid.
PharmacodynamicsPotassium is the principal intracellular cation in most body tissues. The concentration of potassium ions is essential to conduct nerve impulses in specialized tissues like brain, heart and skeletal muscle, as well as to maintain normal renal function, acid-base balance, and cellular metabolic functions. The use of compounds containing bicarbonate is showed to produce the release of CO2. This effect has been one of the problems of the use of potassium bicarbonate as it can cause eructation.
Targets
TargetOrganismActions
Hydrogen ionsneutralizer

ADME / PK

AbsorptionPotassium bicarbonate intake is done mainly in the small intestine in which approximately 90% of the potassium will be absorbed by passive diffusion.
Half-lifeSome reports have shown that after absorption, most body potassium exchanges rapidly with a half-life of less than 7 hours.
Route of eliminationApproximately 90% of the exogenous potassium consumed is lost in the urine while the other 10% is excreted in feces and a very small amount can be found in the sweat. The excreted potassium is freely filtered by the glomerulus of the kidney.

Formulation & handling

  • Potassium bicarbonate is a small molecule API intended for oral administration in various solid and liquid dosage forms, including effervescent tablets and suspensions.
  • The API is highly water-soluble and should be formulated to ensure proper dissolution, particularly for effervescent and solution-based presentations.
  • Caution is advised regarding potassium content in the diet and excipients to avoid hyperkalemia; formulations should consider compatibility with food and instructions to take with a full glass of liquid.

Regulatory status

LifecycleThe API is in a mature lifecycle phase with patent protections expired in the US, Canada, and the EU, allowing for widespread generic availability across these markets. Market activity is primarily focused on generic manufacturing and distribution.
MarketsUS, Canada, EU
Supply Chain
Supply chain summaryThe manufacturing landscape for potassium bicarbonate includes multiple originator companies producing branded products such as Alka-Seltzer Gold and BasoSAN, with market presence across the US, Canada, and the EU. The availability of several branded products suggests a competitive environment, while the absence of patent expiry information indicates that generic competition may already be present or emerging in these regions.

Safety

ToxicityPotassium bicarbonate does not contain any toxic chemicals and it is not listed as a carcinogenic or a potential carcinogen. Potassium bicarbonate is also considered safe in pregnancy as the current data do not suggest a teratogenic potential or any developmental toxicity.
High Level Warnings:
  • Potassium bicarbonate is not classified as a carcinogen or potential carcinogen
  • Current data do not indicate teratogenicity or developmental toxicity
  • Handling should consider its role as an electrolyte to prevent imbalance upon exposure

Potassium hydrogen carbonate is a type of Electrolytes


Electrolytes are a crucial category of pharmaceutical active pharmaceutical ingredients (APIs) that play a vital role in maintaining the balance of essential ions in the body. These ions include sodium, potassium, calcium, magnesium, and chloride, among others. Electrolytes are responsible for maintaining proper hydration, regulating nerve and muscle function, and supporting various physiological processes.

In the pharmaceutical industry, electrolytes are widely utilized in the formulation of oral rehydration solutions, intravenous fluids, and dialysis solutions. These medications are employed to treat conditions such as dehydration, electrolyte imbalances, and renal dysfunction.

The availability of high-quality electrolyte APIs is of utmost importance to ensure the efficacy and safety of these pharmaceutical products. Pharmaceutical manufacturers rely on reputable suppliers who adhere to stringent quality control measures and comply with Good Manufacturing Practices (GMP) to produce electrolyte APIs of consistent quality.

To meet regulatory requirements, electrolyte APIs undergo rigorous testing to confirm their identity, purity, and potency. This includes analysis using advanced techniques such as high-performance liquid chromatography (HPLC), mass spectrometry (MS), and atomic absorption spectroscopy (AAS).

In conclusion, electrolytes are a vital category of pharmaceutical APIs used to maintain the balance of essential ions in the body. They are extensively employed in various medications aimed at treating dehydration, electrolyte imbalances, and renal dysfunction. Pharmaceutical manufacturers prioritize the use of high-quality electrolyte APIs to ensure the safety and efficacy of their products, and adherence to stringent regulatory standards is crucial in their production and testing processes.

Potassium hydrogen carbonate API manufacturers & distributors

Compare qualified Potassium hydrogen carbonate API suppliers worldwide. We currently have 2 companies offering Potassium hydrogen carbonate API, with manufacturing taking place in 2 different countries. Use the table below to review supplier type, countries of origin, certifications, product portfolio and GMP audit availability.

SupplierTypeCountryProduct originCertificationsPortfolio
Distributor
Germany Unknown BSE/TSE, CoA, GMP, ISO9001, MSDS211 products
Producer
France France CoA, GMP93 products

When sending a request, specify which Potassium hydrogen carbonate API quality you need: for example EP (Ph. Eur.), USP, JP, BP, or another pharmacopoeial standard, as well as the required grade (base, salt, micronised, specific purity, etc.).

Use the list above to find high-quality Potassium hydrogen carbonate API suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our help page to learn more about sourcing APIs via Pharmaoffer.